Warm Springs Advisors Inc. Buys New Shares in Stryker Co. (NYSE:SYK)

Warm Springs Advisors Inc. bought a new position in shares of Stryker Co. (NYSE:SYK - Free Report) during the 4th quarter, according to its most recent disclosure with the SEC. The institutional investor bought 3,075 shares of the medical technology company's stock, valued at approximately $1,107,000.

Several other large investors have also recently added to or reduced their stakes in SYK. Kohmann Bosshard Financial Services LLC purchased a new stake in shares of Stryker in the 4th quarter valued at approximately $25,000. Rakuten Securities Inc. increased its position in shares of Stryker by 618.2% in the 4th quarter. Rakuten Securities Inc. now owns 79 shares of the medical technology company's stock valued at $28,000 after purchasing an additional 68 shares during the last quarter. Centricity Wealth Management LLC purchased a new stake in shares of Stryker in the 4th quarter valued at approximately $30,000. BankPlus Trust Department purchased a new stake in shares of Stryker in the 4th quarter valued at approximately $33,000. Finally, Activest Wealth Management acquired a new position in shares of Stryker in the 4th quarter valued at $36,000. 77.09% of the stock is owned by hedge funds and other institutional investors.

Analyst Ratings Changes

Several research analysts have recently issued reports on SYK shares. Canaccord Genuity Group upped their target price on shares of Stryker from $420.00 to $435.00 and gave the company a "buy" rating in a report on Wednesday, January 29th. Citigroup restated a "buy" rating and issued a $455.00 target price (up previously from $443.00) on shares of Stryker in a report on Thursday, May 22nd. Argus set a $450.00 target price on shares of Stryker in a report on Monday, February 3rd. JMP Securities restated a "market perform" rating on shares of Stryker in a report on Monday, May 5th. Finally, Stifel Nicolaus upped their target price on shares of Stryker from $400.00 to $440.00 and gave the company a "buy" rating in a report on Wednesday, January 29th. Five analysts have rated the stock with a hold rating and fifteen have assigned a buy rating to the company's stock. According to MarketBeat, Stryker presently has an average rating of "Moderate Buy" and a consensus target price of $427.30.

Insider Transactions at Stryker

In other news, Director Ronda E. Stryker sold 200,000 shares of Stryker stock in a transaction dated Tuesday, May 6th. The shares were sold at an average price of $376.96, for a total transaction of $75,392,000.00. Following the completion of the sale, the director now directly owns 3,417,326 shares in the company, valued at $1,288,195,208.96. The trade was a 5.53% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is available through the SEC website. Insiders own 5.90% of the company's stock.

Stryker Stock Performance

Shares of SYK stock traded up $7.04 during mid-day trading on Tuesday, hitting $383.66. The stock had a trading volume of 1,099,109 shares, compared to its average volume of 1,347,413. Stryker Co. has a fifty-two week low of $314.93 and a fifty-two week high of $406.19. The firm has a market cap of $146.44 billion, a PE ratio of 49.44, a PEG ratio of 2.93 and a beta of 0.93. The company has a debt-to-equity ratio of 0.59, a current ratio of 1.95 and a quick ratio of 1.32. The company's 50-day simple moving average is $368.04 and its 200-day simple moving average is $376.15.

Stryker (NYSE:SYK - Get Free Report) last announced its earnings results on Thursday, May 1st. The medical technology company reported $2.84 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $2.73 by $0.11. The company had revenue of $5.87 billion during the quarter, compared to analysts' expectations of $5.68 billion. Stryker had a net margin of 13.25% and a return on equity of 23.58%. The firm's quarterly revenue was up 11.9% compared to the same quarter last year. During the same quarter in the previous year, the business posted $2.50 earnings per share. Sell-side analysts anticipate that Stryker Co. will post 13.47 earnings per share for the current year.

Stryker Announces Dividend

The company also recently declared a quarterly dividend, which will be paid on Thursday, July 31st. Stockholders of record on Monday, June 30th will be issued a dividend of $0.84 per share. The ex-dividend date of this dividend is Monday, June 30th. This represents a $3.36 dividend on an annualized basis and a dividend yield of 0.88%. Stryker's dividend payout ratio (DPR) is presently 45.41%.

About Stryker

Stryker Corporation operates as a medical technology company. The company operates through two segments, MedSurg and Neurotechnology, and Orthopaedics and Spine. The Orthopaedics and Spine segment provides implants for use in total joint replacements, such as hip, knee and shoulder, and trauma and extremities surgeries.